Have a personal or library account? Click to login
Severe perinatal hemolytic disease due to anti-e Cover

Severe perinatal hemolytic disease due to anti-e

Immunohematology
Volume 37 (2021): Issue 2 (June 2021)
By: G. Soler-Noda,  Y. Romero-Díaz,  L. Orbeal-Aldama and  S. Aquino-Rojas  
Paid access
|Jun 2021

Authors

G. Soler-Noda

gsolern@infomed.sld.cu

Laboratory of Immunohematology, National Institute of Hematology and Immunology, Habana, Cuba

Y. Romero-Díaz

Laboratory of Immunohematology, National Institute of Hematology and Immunology, Habana, Cuba

L. Orbeal-Aldama

Laboratory of Immunohematology, National Institute of Hematology and Immunology, Habana, Cuba

S. Aquino-Rojas

Laboratory of Immunohematology, National Institute of Hematology and Immunology, Habana, Cuba
DOI: https://doi.org/10.21307/immunohematology-2021-011 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 72 - 77
Published on: Jun 25, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hemolytic disease of the fetus and newborn,
HDFN,
postnatal diagnosis,
Rh blood group system,
Rhe,
Rh5
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2021 G. Soler-Noda, Y. Romero-Díaz, L. Orbeal-Aldama, S. Aquino-Rojas, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 37 (2021): Issue 2 (June 2021)Next article